SPIC
geneOn this page
Also known as MGC40611SPI-C
Summary
SPIC (Spi-C transcription factor, HGNC:29549) is a protein-coding gene on chromosome 12q23.2, encoding Transcription factor Spi-C (Q8N5J4). Controls the development of red pulp macrophages required for red blood cells recycling and iron homeostasis. It is a selective cancer dependency (DepMap: 11.1% of cell lines).
The protein encoded by this gene regulates the development of red pulp macrophages, which are necessary for iron homeostasis and the recycling of red blood cells.
Source: NCBI Gene 121599 — RefSeq curated summary.
At a glance
- GWAS associations: 11
- Clinical variants (ClinVar): 33 total
- Cancer dependency (DepMap): dependent in 11.1% of screened cell lines
- Transcription factor: yes — 11 downstream targets (CollecTRI)
- MANE Select transcript:
NM_152323
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29549 |
| Approved symbol | SPIC |
| Name | Spi-C transcription factor |
| Location | 12q23.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC40611, SPI-C |
| Ensembl gene | ENSG00000166211 |
| Ensembl biotype | protein_coding |
| OMIM | 612568 |
| Entrez | 121599 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000551346
RefSeq mRNA: 1 — MANE Select: NM_152323
NM_152323
CCDS: CCDS9082
Canonical transcript exons
ENST00000551346 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001101045 | 101482792 | 101482900 |
| ENSE00001101052 | 101477558 | 101477651 |
| ENSE00001101055 | 101479582 | 101479694 |
| ENSE00002374098 | 101476828 | 101476907 |
| ENSE00002379201 | 101486344 | 101486997 |
| ENSE00002417353 | 101475336 | 101475502 |
Expression profiles
Bgee: expression breadth broad, 43 present calls, max score 83.11.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2639 / max 152.4258, expressed in 43 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 127605 | 0.2639 | 43 |
Top tissues by expression
214 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| spleen | UBERON:0002106 | 83.11 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.52 | gold quality |
| lymph node | UBERON:0000029 | 66.93 | gold quality |
| bone marrow cell | CL:0002092 | 57.48 | gold quality |
| vermiform appendix | UBERON:0001154 | 53.35 | gold quality |
| liver | UBERON:0002107 | 50.69 | gold quality |
| caecum | UBERON:0001153 | 50.39 | gold quality |
| tonsil | UBERON:0002372 | 48.75 | gold quality |
| right lobe of liver | UBERON:0001114 | 48.18 | gold quality |
| bone marrow | UBERON:0002371 | 45.24 | gold quality |
| cortical plate | UBERON:0005343 | 45.22 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 44.36 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| granulocyte | CL:0000094 | 43.28 | silver quality |
| lower lobe of lung | UBERON:0008949 | 42.78 | silver quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 42.20 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-3929 | yes | 81.90 |
| E-ANND-3 | no | 2.45 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
11 targets.
| Target | Regulation |
|---|---|
| ADM | |
| CD5L | Activation |
| FCER1G | |
| FCER2 | Activation |
| IGH | |
| IL4 | Activation |
| MMP12 | Activation |
| PREB | |
| PRF1 | |
| SPI1 | |
| TFAP2A |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0687.1 | SPIC | Ets-related |
| MA0687.2 | SPIC | Ets-related |
JASPAR matrix evidence (PMIDs): PMID:16887979
miRNA regulators (miRDB)
25 targeting SPIC, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-766-5P | 99.47 | 67.91 | 2225 |
| HSA-MIR-5009-3P | 99.45 | 69.43 | 1341 |
| HSA-MIR-513A-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-513C-3P | 99.39 | 70.63 | 3620 |
| HSA-MIR-3606-3P | 99.11 | 69.84 | 3254 |
| HSA-MIR-6878-5P | 98.49 | 67.91 | 2142 |
| HSA-MIR-6881-3P | 98.04 | 68.24 | 1777 |
| HSA-MIR-6847-5P | 97.93 | 66.74 | 1808 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 11.1% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 2)
- A protein interaction between SPI-C and STAT6 is the basis for a novel mechanism for regulation of IL4 induced gene expression. (PMID:16647686)
- Spi-C positively regulates RANKL-mediated osteoclast differentiation and function. (PMID:32341419)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spic | ENSDARG00000012435 |
| mus_musculus | Spic | ENSMUSG00000004359 |
| rattus_norvegicus | Spic | ENSRNOG00000005720 |
Paralogs (28): ETV1 (ENSG00000006468), ETV7 (ENSG00000010030), SPI1 (ENSG00000066336), ELF4 (ENSG00000102034), ETV2 (ENSG00000105672), ERF (ENSG00000105722), ELF2 (ENSG00000109381), ELK3 (ENSG00000111145), ETV3 (ENSG00000117036), ELF1 (ENSG00000120690), SPDEF (ENSG00000124664), ELK1 (ENSG00000126767), ETS1 (ENSG00000134954), EHF (ENSG00000135373), ELF5 (ENSG00000135374), ETV6 (ENSG00000139083), FLI1 (ENSG00000151702), GABPA (ENSG00000154727), ERG (ENSG00000157554), ETS2 (ENSG00000157557), ELK4 (ENSG00000158711), ELF3 (ENSG00000163435), FEV (ENSG00000163497), ETV4 (ENSG00000175832), ETV5 (ENSG00000244405), ETV3L (ENSG00000253831), ERFL (ENSG00000268041), SPIB (ENSG00000269404)
Protein
Protein identifiers
Transcription factor Spi-C — Q8N5J4 (reviewed: Q8N5J4)
All UniProt accessions (1): Q8N5J4
UniProt curated annotations — full annotation on UniProt →
Function. Controls the development of red pulp macrophages required for red blood cells recycling and iron homeostasis. Transcription factor that binds to the PU-box, a purine-rich DNA sequence (5’-GAGGA[AT]-3’) that can act as a lymphoid-specific enhancer. Regulates VCAM1 gene expression.
Subunit / interactions. Binds DNA as a monomer.
Subcellular location. Nucleus.
Tissue specificity. Preferentially detected in fetal and adult spleen, lymph nodes and at lower levels in bone marrow and fetal liver.
Similarity. Belongs to the ETS family.
RefSeq proteins (1): NP_689536* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000418 | Ets_dom | Domain |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
| IPR046328 | ETS_fam | Family |
Pfam: PF00178
UniProt features (2 total): chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N5J4-F1 | 67.85 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 115 (showing top):
GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING, DARWICHE_SKIN_TUMOR_PROMOTER_UP, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_UP, DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP, GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT, FOSTER_TOLERANT_MACROPHAGE_DN, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, GOBP_BLASTOCYST_DEVELOPMENT, GOBP_EMBRYO_DEVELOPMENT, LIAN_LIPA_TARGETS_3M, GARY_CD5_TARGETS_UP, chr12q23, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, CHEN_METABOLIC_SYNDROM_NETWORK
GO Biological Process (5): blastocyst development (GO:0001824), regulation of transcription by RNA polymerase II (GO:0006357), cell differentiation (GO:0030154), regulation of DNA-templated transcription (GO:0006355), positive regulation of transcription by RNA polymerase II (GO:0045944)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| in utero embryonic development | 1 |
| anatomical structure development | 1 |
| cellular developmental process | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| positive regulation of DNA-templated transcription | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription activator activity | 1 |
| positive regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| binding | 1 |
| DNA binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
316 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPIC | NIPSNAP3A | Q9UFN0 | 934 |
| SPIC | NIPSNAP3B | Q9BS92 | 840 |
| SPIC | LAMP1 | P11279 | 581 |
| SPIC | ABCA1 | O95477 | 520 |
| SPIC | HOOK3 | Q86VS8 | 511 |
| SPIC | HPX | P02790 | 401 |
| SPIC | GATA6 | P78327 | 400 |
| SPIC | CPZ | Q66K79 | 385 |
| SPIC | SLC40A1 | Q9NP59 | 372 |
| SPIC | NR1H3 | Q13133 | 369 |
| SPIC | ANO4 | Q32M45 | 352 |
| SPIC | CLEC4F | Q8N1N0 | 321 |
| SPIC | GTSF1 | Q8WW33 | 312 |
| SPIC | SLC48A1 | Q6P1K1 | 306 |
| SPIC | VSIG10 | Q8N0Z9 | 305 |
IntAct
17 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MEOX1 | SPIC | psi-mi:“MI:0915”(physical association) | 0.560 |
| INTS11 | SPIC | psi-mi:“MI:0915”(physical association) | 0.560 |
| NFE2L2 | SPIC | psi-mi:“MI:0915”(physical association) | 0.370 |
| SPIC | psi-mi:“MI:0915”(physical association) | 0.370 | |
| CCL24 | SPIC | psi-mi:“MI:0915”(physical association) | 0.370 |
| IFNA2 | SPIC | psi-mi:“MI:0915”(physical association) | 0.370 |
| IL18 | SPIC | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | SPIC | psi-mi:“MI:0915”(physical association) | 0.370 |
| SPIC | MEOX1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPIC | INTS11 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): SPIC (Two-hybrid), SPIC (Two-hybrid), SPIC (Two-hybrid), SPIC (Affinity Capture-MS), APP (Reconstituted Complex)
ESM2 similar proteins: A0FIN4, A6NI15, B1WBU4, D2HNW6, D4A7U2, O35906, O43734, P10914, P14316, P15314, P17433, P17947, P23570, P23906, P97303, P97432, Q01892, Q17RD7, Q1LY51, Q1RML4, Q3SZP0, Q4V7B1, Q501R9, Q505G8, Q5EBA3, Q5SUE8, Q66HA2, Q6AI12, Q6BDS1, Q6P3D7, Q6PKU1, Q6ZNC4, Q7TN83, Q8BSV3, Q8HWS3, Q8N5J4, Q8N7W2, Q8R4E0, Q8VHI4, Q90876
Diamond homologs: A0A1W2PQ73, A0JN51, A1A4L6, A1YF15, A1YG61, A1YG91, A2D4Z7, A2T737, A2T762, A3FEM2, A4GTP4, A8WFJ9, O00321, O01519, O35906, O70132, O70273, O95238, P01105, P10157, P11536, P13474, P14921, P15062, P17433, P17947, P18755, P18756, P19102, P19419, P20105, P27577, P28322, P28324, P29773, P29774, P29776, P32519, P41156, P41158
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 1 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
815 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:101477556:A:AG | acceptor_gain | 1.0000 |
| 12:101477557:G:GG | acceptor_gain | 1.0000 |
| 12:101477557:GAC:G | acceptor_gain | 1.0000 |
| 12:101477557:GACGT:G | acceptor_gain | 1.0000 |
| 12:101477648:CCAG:C | donor_loss | 1.0000 |
| 12:101477649:CAG:C | donor_loss | 1.0000 |
| 12:101477650:AG:A | donor_loss | 1.0000 |
| 12:101477651:GGTAA:G | donor_loss | 1.0000 |
| 12:101477653:T:A | donor_loss | 1.0000 |
| 12:101482789:T:G | acceptor_gain | 1.0000 |
| 12:101482789:TAGAA:T | acceptor_loss | 1.0000 |
| 12:101482790:A:AG | acceptor_gain | 1.0000 |
| 12:101482790:A:C | acceptor_loss | 1.0000 |
| 12:101482791:G:GA | acceptor_gain | 1.0000 |
| 12:101482791:GA:G | acceptor_gain | 1.0000 |
| 12:101482791:GAAC:G | acceptor_gain | 1.0000 |
| 12:101482791:GAACA:G | acceptor_gain | 1.0000 |
| 12:101482900:GG:G | donor_loss | 1.0000 |
| 12:101482901:GTAC:G | donor_loss | 1.0000 |
| 12:101482902:T:G | donor_loss | 1.0000 |
| 12:101475500:CCGG:C | donor_loss | 0.9900 |
| 12:101475501:CGG:C | donor_loss | 0.9900 |
| 12:101476860:A:G | acceptor_gain | 0.9900 |
| 12:101477553:AACAG:A | acceptor_loss | 0.9900 |
| 12:101477554:ACAG:A | acceptor_loss | 0.9900 |
| 12:101477555:CAGAC:C | acceptor_loss | 0.9900 |
| 12:101477556:A:C | acceptor_loss | 0.9900 |
| 12:101477658:A:G | donor_gain | 0.9900 |
| 12:101479695:G:GG | donor_gain | 0.9900 |
| 12:101482791:GAA:G | acceptor_gain | 0.9900 |
AlphaMissense
1640 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:101486484:T:A | W154R | 1.000 |
| 12:101486484:T:C | W154R | 1.000 |
| 12:101486418:T:A | W132R | 0.999 |
| 12:101486418:T:C | W132R | 0.999 |
| 12:101486443:T:C | F140S | 0.999 |
| 12:101486449:T:C | F142S | 0.999 |
| 12:101486465:A:C | K147N | 0.999 |
| 12:101486465:A:T | K147N | 0.999 |
| 12:101486476:C:A | A151D | 0.999 |
| 12:101486485:G:C | W154S | 0.999 |
| 12:101486486:G:C | W154C | 0.999 |
| 12:101486486:G:T | W154C | 0.999 |
| 12:101486487:G:A | G155R | 0.999 |
| 12:101486487:G:C | G155R | 0.999 |
| 12:101486515:T:C | M164T | 0.999 |
| 12:101486516:G:A | M164I | 0.999 |
| 12:101486516:G:C | M164I | 0.999 |
| 12:101486516:G:T | M164I | 0.999 |
| 12:101486520:T:C | Y166H | 0.999 |
| 12:101486542:T:A | L173H | 0.999 |
| 12:101486545:G:C | R174T | 0.999 |
| 12:101486546:A:C | R174S | 0.999 |
| 12:101486546:A:T | R174S | 0.999 |
| 12:101486602:T:C | F193S | 0.999 |
| 12:101486362:T:A | L113Q | 0.998 |
| 12:101486374:T:C | L117P | 0.998 |
| 12:101486420:G:C | W132C | 0.998 |
| 12:101486420:G:T | W132C | 0.998 |
| 12:101486442:T:C | F140L | 0.998 |
| 12:101486444:T:A | F140L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000266836 (12:101478342 CTTTAA>C), RS1000468963 (12:101485299 G>T), RS1000496178 (12:101480449 T>C), RS1000597179 (12:101486258 T>A,C), RS1000632210 (12:101480182 C>A,T), RS1000688355 (12:101473385 C>A), RS1000698540 (12:101487255 C>A), RS1000977710 (12:101473822 G>T), RS1001108640 (12:101473972 T>C), RS1001209002 (12:101486939 G>A), RS1001417404 (12:101474192 C>A,T), RS1001647142 (12:101484838 A>C,G), RS1001783396 (12:101480852 T>C,G), RS1001841904 (12:101486848 T>A,G), RS1001865151 (12:101479268 A>C)
Disease associations
OMIM: gene MIM:612568 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
11 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002408_10 | Response to methotrexate in juvenile idiopathic arthritis | 5.000000e-06 |
| GCST004627_143 | Lymphocyte count | 2.000000e-10 |
| GCST004747_21 | Lung cancer in never smokers | 7.000000e-06 |
| GCST006611_137 | HDL cholesterol | 9.000000e-12 |
| GCST008156_74 | Hip circumference adjusted for BMI | 5.000000e-06 |
| GCST010242_91 | HDL cholesterol levels | 3.000000e-08 |
| GCST90002386_331 | High light scatter reticulocyte percentage of red cells | 2.000000e-09 |
| GCST90002388_437 | Lymphocyte count | 5.000000e-14 |
| GCST90002388_438 | Lymphocyte count | 4.000000e-23 |
| GCST90002406_343 | Reticulocyte fraction of red cells | 2.000000e-09 |
| GCST90002407_292 | White blood cell count | 1.000000e-17 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004587 | lymphocyte count |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Arsenic | affects methylation | 1 |
| Demecolcine | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Vincristine | increases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A6Q3 | SEES3-1V human SPIC, clone1 | Embryonic stem cell | Male |
| CVCL_A6Q4 | SEES3-1V human SPIC, clone2 | Embryonic stem cell | Male |
| CVCL_A6Q5 | SEES3-1V human SPIC, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): juvenile idiopathic arthritis